You have 9 free searches left this month | for more free features.

Somatostatinoma

Showing 1 - 25 of 28

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gastrinoma, Glucagonoma, Insulinoma Trial in United States (regorafenib, laboratory biomarker analysis)

Completed
  • Gastrinoma
  • +8 more
  • Scottsdale, Arizona
  • +4 more
Nov 15, 2021

Adult Medulloblastoma, Childhood Medulloblastoma, Neuroblastoma Trial in Iowa City (drug, procedure, radiation)

Completed
  • Adult Medulloblastoma
  • +4 more
  • gallium Ga 68-edotreotide
  • +4 more
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Aug 26, 2021

Gastrinoma, Glucagonoma, Insulinoma Trial in Stanford (Capecitabine, Temozolomide, Bevacizumab)

Completed
  • Gastrinoma
  • +8 more
  • Stanford, California
    Stanford University Medical Center
Apr 8, 2021

Gastrinoma, Glucagonoma, Insulinoma Trial in Boston (everolimus, )

Terminated
  • Gastrinoma
  • +6 more
  • Boston, Massachusetts
    Ecog-Acrin
Dec 1, 2020

Gastrin-Producing Neuroendocrine Tumor, Lung Carcinoid Tumor, Metastatic Digestive System Neuroendocrine Tumor G1 Trial in

Completed
  • Gastrin-Producing Neuroendocrine Tumor
  • +10 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Boston, Massachusetts
  • +2 more
Mar 25, 2020

Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma, Endometrial Serous Adenocarcinoma Trial in Canada,

Completed
  • Adult Hepatocellular Carcinoma
  • +44 more
  • Scottsdale, Arizona
  • +60 more
Jan 24, 2019

Gastrinoma, Glucagonoma, Insulinoma Trial (dovitinib lactate, pharmacological study, laboratory biomarker analysis)

Withdrawn
  • Gastrinoma
  • +5 more
  • dovitinib lactate
  • +2 more
  • (no location specified)
Jul 18, 2017

Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Lung Cancer Trial in San Francisco, Vallejo (bevacizumab, 5-fluorouracil,

Terminated
  • Gastrointestinal Carcinoid Tumor
  • +4 more
  • bevacizumab
  • +3 more
  • San Francisco, California
  • +1 more
Dec 12, 2019

Functional Pancreatic Neuroendocrine Tumor, Malignant Somatostatinoma, Merkel Cell Carcinoma Trial (Capecitabine, Temozolomide,

Withdrawn
  • Functional Pancreatic Neuroendocrine Tumor
  • +28 more
  • (no location specified)
Sep 26, 2017

Pancreatic Cancer Trial in Minneapolis (Bortezomib, Panobinostat)

Terminated
  • Pancreatic Cancer
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Dec 3, 2017

Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Metastatic Cancer Trial in Baltimore (PVA microporous

Terminated
  • Gastrointestinal Carcinoid Tumor
  • +2 more
  • PVA microporous hydrospheres/doxorubicin hydrochloride
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jul 24, 2017

Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Neoplastic Syndrome Trial (fluorouracil, irinotecan HCl, leucovorin calcium)

Completed
  • Gastrointestinal Carcinoid Tumor
  • +2 more
  • (no location specified)
May 27, 2016

Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Neoplastic Syndrome Trial in United States (AMG 706, octreotide)

Completed
  • Gastrointestinal Carcinoid Tumor
  • +2 more
  • Berwyn, Illinois
  • +111 more
Jul 12, 2016

Gastrointestinal Carcinoid Tumor, Islet Cell Carcinoma Trial (octreotide acetate, vatalanib, anti-cytokine therapy)

Withdrawn
  • Gastrointestinal Carcinoid Tumor
  • Islet Cell Carcinoma
  • octreotide acetate
  • +10 more
  • (no location specified)
Oct 6, 2015

Brain and CNS Tumors, Childhood Langerhans Cell Histiocytosis, Gastrointestinal Carcinoid Tumor Trial in New Haven (indium In

Terminated
  • Brain and Central Nervous System Tumors
  • +11 more
  • indium In 111 pentetreotide
  • New Haven, Connecticut
    Yale Comprehensive Cancer Center
Jul 1, 2014

Quality of Life in Gastrointestinal-Related Neuroendocrine

Unknown status
  • Gastrointestinal Carcinoid Tumor
  • +4 more
  • questionnaire administration
  • quality-of-life assessment
  • Aarhus, Denmark
  • +15 more
Oct 28, 2013

Cancer Trial run by the (isolated perfusion, melphalan)

Completed
  • Cancer
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Trials Refe
Oct 22, 2013

Merkel Cell Carcinoma, Islet Cell Carcinoma, Neuroendocrine Carcinoma Trial in Houston (antineoplaston A10, antineoplaston

Withdrawn
  • Merkel Cell Carcinoma
  • +3 more
  • antineoplaston A10
  • +7 more
  • Houston, Texas
    Burzynski Clinic
Jul 9, 2013

Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Lung Cancer Trial in New York (thalidomide)

Completed
  • Gastrointestinal Carcinoid Tumor
  • +3 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 17, 2013

Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer, Bone Metastases Trial in Columbus (recombinant interleukin-12,

Completed
  • Advanced Adult Primary Liver Cancer
  • +126 more
  • recombinant interleukin-12
  • ABI-007/carboplatin/trastuzumab
  • Columbus, Ohio
    Ohio State University Medical Center
Feb 27, 2013

Gastrointestinal Carcinoid Tumor, Islet Cell Tumor Trial in United Kingdom (drug, genetic, other)

Completed
  • Gastrointestinal Carcinoid Tumor
  • Islet Cell Tumor
  • Basildon, England, United Kingdom
  • +16 more
Aug 6, 2013

Cancer Trial in Chandler (Fentanyl sublingual spray, Placebo)

Completed
  • Cancer
  • Fentanyl sublingual spray
  • Placebo
  • Chandler, Arizona
    InSys Therapeutics, Incorporated
Jan 14, 2014

Brain and CNS Tumors, Breast Cancer, Gastrointestinal Carcinoid Tumor Trial in Tampa (yttrium Y 90-edotreotide)

Completed
  • Brain and Central Nervous System Tumors
  • +7 more
  • yttrium Y 90-edotreotide
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Apr 30, 2013

Gastrointestinal Carcinoid Tumor, Islet Cell Tumor Trial in Chicago, Columbus (bortezomib)

Completed
  • Gastrointestinal Carcinoid Tumor
  • Islet Cell Tumor
  • Chicago, Illinois
  • +1 more
Jan 30, 2013